These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 21366417)

  • 1. Development of new vaccines and drugs for TB: limitations and potential strategic errors.
    Orme IM
    Future Microbiol; 2011 Feb; 6(2):161-77. PubMed ID: 21366417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and novel approaches to vaccine development against tuberculosis.
    Cayabyab MJ; Macovei L; Campos-Neto A
    Front Cell Infect Microbiol; 2012; 2():154. PubMed ID: 23230563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal Models of Tuberculosis: An Overview.
    Williams A; Orme IM
    Microbiol Spectr; 2016 Aug; 4(4):. PubMed ID: 27726810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis in Africa: learning from pathogenesis for biomarker identification.
    Kaufmann SH; Parida SK
    Cell Host Microbe; 2008 Sep; 4(3):219-28. PubMed ID: 18779048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Human Primate Models of Tuberculosis.
    Peña JC; Ho WZ
    Microbiol Spectr; 2016 Aug; 4(4):. PubMed ID: 27726820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current state of tuberculosis vaccines.
    Hokey DA; Ginsberg A
    Hum Vaccin Immunother; 2013 Oct; 9(10):2142-6. PubMed ID: 23792698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards new TB vaccines: What are the challenges?
    Dockrell HM
    Pathog Dis; 2016 Jun; 74(4):ftw016. PubMed ID: 26960944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming the global crisis: "yes, we can", but also for TB ... ?
    Ottenhoff TH
    Eur J Immunol; 2009 Aug; 39(8):2014-20. PubMed ID: 19672895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis vaccine research: the impact of immunology.
    Barker LF; Brennan MJ; Rosenstein PK; Sadoff JC
    Curr Opin Immunol; 2009 Jun; 21(3):331-8. PubMed ID: 19505813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achieving STOP TB Partnership goals: perspectives on development of new diagnostics, drugs and vaccines for tuberculosis.
    Mwaba P; McNerney R; Grobusch MP; O'Grady J; Bates M; Kapata N; Maeurer M; Zumla A
    Trop Med Int Health; 2011 Jul; 16(7):819-27. PubMed ID: 21489070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis clinical trial update and the current anti-tuberculosis drug portfolio.
    Palomino JC; Martin A
    Curr Med Chem; 2013; 20(30):3785-96. PubMed ID: 23862617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.
    Dietrich J; Doherty TM
    APMIS; 2009 May; 117(5-6):440-57. PubMed ID: 19400867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccine.
    Fu H; Lewnard JA; Frost I; Laxminarayan R; Arinaminpathy N
    Nat Commun; 2021 Jan; 12(1):424. PubMed ID: 33462224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis: current treatment, diagnostics, and newer antitubercular agents in clinical trials.
    Ahsan MJ; Ansari MY; Yasmin S; Jadav SS; Kumar P; Garg SK; Aseri A; Khalilullah H
    Infect Disord Drug Targets; 2015; 15(1):32-41. PubMed ID: 25246035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New drugs and vaccines for drug-resistant Mycobacterium tuberculosis infections.
    Dover LG; Bhatt A; Bhowruth V; Willcox BE; Besra GS
    Expert Rev Vaccines; 2008 May; 7(4):481-97. PubMed ID: 18444894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection.
    Lin MY; Ottenhoff TH
    Biol Chem; 2008 May; 389(5):497-511. PubMed ID: 18953716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for developing tuberculosis vaccines: emerging approaches.
    Mollica A; Stefanucci A; Costante R
    Curr Drug Targets; 2013 Aug; 14(9):938-51. PubMed ID: 23469877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chasing Koch's chimera.
    Klatser P; Anthony R; Barry C; Drobniewski F; Hoffner S; Niemann S; Gillespie S
    Lancet Infect Dis; 2013 Apr; 13(4):289-91. PubMed ID: 23538218
    [No Abstract]   [Full Text] [Related]  

  • 19. Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery.
    de Wet TJ; Warner DF; Mizrahi V
    Acc Chem Res; 2019 Aug; 52(8):2340-2348. PubMed ID: 31361123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis vaccines: hopes and hurdles.
    Ahsan MJ; Garg SK; Vashistha B; Sharma P
    Infect Disord Drug Targets; 2013 Oct; 13(5):318-21. PubMed ID: 24304353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.